Nalaganje...
FDA Approvals of Brand-Name Prescription Drugs in 2015
I. New Pharmaceuticals: New Molecular Entities and New Biologic License Applications. II. New Combinations and New Indications. III. New Dosage Forms and New Formulations. IV. New Biosimilars, Vaccines, Viral Therapies, and Blood Products.
Shranjeno v:
| izdano v: | Am Health Drug Benefits |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Engage Healthcare Communications, LLC
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013848/ https://ncbi.nlm.nih.gov/pubmed/27668042 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|